Search Results - "Manuel‐y‐Keenoy, B."

Refine Results
  1. 1

    Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: Discordant in vitro and in vivo dose-effects: A review by Sadowska, A.M, Manuel-y-Keenoy, B, De Backer, W.A

    Published in Pulmonary pharmacology & therapeutics (01-01-2007)
    “…Abstract In order to develop efficient therapeutic regimes for chronic obstructive pulmonary disease (COPD), N -acetylcysteine (NAC) has been tested as a…”
    Get full text
    Journal Article
  2. 2

    Prevalence and socioeconomic differences of risk factors of cardiovascular disease in Ecuadorian adolescents by Ochoa-Avilés, A., Andrade, S., Huynh, T., Verstraeten, R., Lachat, C., Rojas, R., Donoso, S., Manuel-y-Keenoy, B., Kolsteren, P.

    Published in Pediatric obesity (01-08-2012)
    “…Summary Purpose The aim of this paper is to report the prevalence of cardiovascular risk factors and socioeconomic differences in school‐going Ecuadorian…”
    Get full text
    Journal Article
  3. 3

    Decreased paraoxonase 2 enzymatic activity in monocyte/macrophages cells. A comparative in vivo and in vitro study for diabetes by Lixandru, D, Alexandru, P, Mihai, A, Roşca, A, Ionescu-Tîrgovişte, C, Braşoveanu, L I, Manuel-Y-Keenoy, B

    Published in Free radical research (03-06-2017)
    “…To investigate peripheral blood monocytes/macrophages (Mo/Mᴓ) paraoxonase 2 (PON2) in diabetes and the factors modulating its activity. One hundred and…”
    Get more information
    Journal Article
  4. 4

    Divergent in vitro and in vivo lipid peroxidation in the postprandial phase of patients with type I diabetes mellitus by Manuel-y-Keenoy, B, Vos, C. de, Campenhout, A. van, Vinckx, M, Abrams, P, Campenhout, C. van

    Published in European journal of clinical nutrition (01-03-2008)
    “…Objective: The two- to fourfold higher risk of cardiovascular disease in diabetes mellitus is more strongly predicted by the postprandial than by the fasting…”
    Get full text
    Journal Article
  5. 5

    Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers? by Hoydonck, P.G.A. van, Schouten, E.G, Manuel-y-Keenoy, B, Campenhout, A. van, Hoppenbrouwers, K.P.M, Temme, E.H.M

    Published in European journal of clinical nutrition (01-12-2004)
    “…To examine the effects of vitamin C supplementation on the concentration of oxidation markers, in particular, circulating oxidized LDL (OxLDL) and on…”
    Get full text
    Journal Article
  6. 6

    Inhibition of in vitro neutrophil migration through a bilayer of endothelial and epithelial cells using beta2-agonists: concomitant effects on IL-8 and elastase secretion and impact of glucocorticosteroids by Sadowska, A M, Manuel-y-Keenoy, B, De Backer, W A

    Published in Pulmonary pharmacology & therapeutics (01-10-2005)
    “…Beta2-agonists and glucocorticosteroids are two common treatments for COPD and they are often used in combination. Glucocorticosteroids mediate the…”
    Get full text
    Journal Article
  7. 7

    Effects of intravenous supplementation with α-tocopherol in patients receiving total parenteral nutrition containing medium- and long-chain triglycerides by MANUEL-Y-KEENOY, B, NONNEMAN, L, DE BOSSCHER, H, VERTOMMEN, J, SCHRANS, S, KLÜTSCH, K, DE LEEUW, I

    Published in European journal of clinical nutrition (01-02-2002)
    “…To compare the effects of a lipid emulsion containing medium-chain triglycerides (MCT) and supplemented with alpha-tocopherol to a conventional long-chain…”
    Get full text
    Journal Article
  8. 8

    Effects of micronized fenofibrate and vitamin E on in vitro oxidation of lipoproteins in patients with type 1 diabetes mellitus by Engelen, W, Manuel-Y-Keenoy, B, Vertommen, J, De Leeuw, I, Van Gaal, L

    Published in Diabetes & metabolism (01-04-2005)
    “…The primary objective was to compare the antioxidant activity of micronised fenofibrate 200 mg to 400 IU of vitamin E and placebo, on the LDL and VLDL…”
    Get full text
    Journal Article
  9. 9

    Real-time continuous glucose monitoring in the ICU by Gios, J, Manuel-y-Keenoy, B, Rogiers, P

    Published in Critical care (London, England) (01-01-2015)
    “…Whether applying intensive insulin therapy to achieve tight glycemic control in critically ill patients is beneficial remains controversial [2]. [...]we can…”
    Get full text
    Journal Article
  10. 10

    Iron-binding antioxidant capacity is impaired in diabetes mellitus by Van Campenhout, Ann, Van Campenhout, Christel, Lagrou, Albert R., Moorkens, Greta, De Block, Christophe, Manuel-y-Keenoy, Begoña

    Published in Free radical biology & medicine (15-05-2006)
    “…Increased lipid peroxidation contributes to diabetic complications and redox-active iron is known to play an important role in catalyzing peroxidation…”
    Get full text
    Journal Article
  11. 11

    Oxidative stress status in patients with diabetes mellitus: relationship to diet by DIERCKX, N, HORVATH, G, VAN GILS, C, VERTOMMEN, J, VAN DE VLIET, J, DE LEEUW, I, MANUEL-Y-KEENOY, B

    Published in European journal of clinical nutrition (01-08-2003)
    “…To investigate the relationship between dietary intakes and in vivo oxidative stress (OS) status in diabetic patients. Case-control study. Outpatient-Clinic…”
    Get full text
    Journal Article
  12. 12

    Metabolism of tritiated D-glucose in rat erythrocytes by Manuel y Keenoy, B, Malaisse-Lagae, F, Malaisse, W J

    Published in Metabolism, clinical and experimental (01-09-1991)
    “…The metabolism of D-[U-14C]glucose, D-[1-14C]glucose, D-[6-14C]glucose, D-[1-3H]glucose, D-[2-3H]glucose, D-[3-3H]glucose, D-[3,4-3H]glucose, D-[5-3H]glucose,…”
    Get more information
    Journal Article
  13. 13

    The effect of flavonoid treatment on the glycation and antioxidant status in Type 1 diabetic patients by Manuel y Keenoy, B, Vertommen, J, De Leeuw, I

    Published in Diabetes, nutrition & metabolism (01-08-1999)
    “…Amongst the numerous co-adjuvant therapies which could influence the incidence and progression of diabetic complications, antioxidants and flavonoids are…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Prevalence and socioeconomic differences of risk factors of cardiovascular disease in E cuadorian adolescents by Ochoa‐Avilés, A., Andrade, S., Huynh, T., Verstraeten, R., Lachat, C., Rojas, R., Donoso, S., ManuelyKeenoy, B., Kolsteren, P.

    Published in Pediatric obesity (01-08-2012)
    “…Summary Purpose The aim of this paper is to report the prevalence of cardiovascular risk factors and socioeconomic differences in school‐going E cuadorian…”
    Get full text
    Journal Article
  16. 16

    Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome by y Keenoy, Begoña Manuel, Moorkens, Greta, Vertommen, Jan, De Leeuw, Ivo

    Published in Life sciences (1973) (16-03-2001)
    “…The aetiology and pathogenesis of the Chronic Fatigue Syndrome (CFS) are still largely unresolved. Accompanying metabolic disorders such as selective n-6 fatty…”
    Get full text
    Journal Article
  17. 17

    Effect of N-acetylcysteine on neutrophil activation markers in healthy volunteers: In vivo and in vitro study by Sadowska, Anna M., Manuel-y-Keenoy, Begoña, Vertongen, Tim, Schippers, Glenn, Radomska-Lesniewska, Dorota, Heytens, Elke, De Backer, Wilfried A.

    Published in Pharmacological research (01-03-2006)
    “…Neutrophil activation is implicated in the pathogenesis of inflammatory processes such as chronic obstructive pulmonary disease (COPD). We wished to evaluate…”
    Get full text
    Journal Article
  18. 18

    Significance of 3HOH generation from D-[2-3H]glucose by Manuel y Keenoy, B, Malaisse, W J

    Published in Diabetes research (Edinburgh, Scotland) (01-03-1992)
    “…The significance of 3HOH generation by cells exposed to D-[2-3H]glucose is reevaluated. It is proposed that such a metabolic variable, rather than being taken…”
    Get more information
    Journal Article
  19. 19

    Effects of in Vitro Glycation on Fe3+ Binding and Fe3+ Isoforms of Transferrin by Van Campenhout, Ann, Van Campenhout, Christel, Lagrou, Albert Rene, Manuel-y-Keenoy, Begona

    Published in Clinical chemistry (Baltimore, Md.) (01-09-2004)
    “…In diabetes, protein function is altered by glycation, but the impact on the Fe3+ binding and antioxidant functions of transferrin (Tf) is largely unknown. The…”
    Get full text
    Journal Article
  20. 20